AR011521A1 - Un derivado de la prolil-3-(2-naftil) alanil-n-bencil-n-metilamida, un procedimiento para su preparacion y una composicion farmaceutica que lo comprende - Google Patents
Un derivado de la prolil-3-(2-naftil) alanil-n-bencil-n-metilamida, un procedimiento para su preparacion y una composicion farmaceutica que lo comprendeInfo
- Publication number
- AR011521A1 AR011521A1 ARP980100097A ARP980100097A AR011521A1 AR 011521 A1 AR011521 A1 AR 011521A1 AR P980100097 A ARP980100097 A AR P980100097A AR P980100097 A ARP980100097 A AR P980100097A AR 011521 A1 AR011521 A1 AR 011521A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- derivative
- methylamide
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Addiction (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un derivado de la prolil-3-(2-naftil)alanil-N-bencil-N-metilamida, que responde a la formula (I), en donde X es -CH2- o un enlace directo; Y es -O-,-S-, o -NH; R1 es fenilo; R2 = H o fenilo; y R3 es H o -CH3-, y sus sales farmacéuticamenteaceptables, tienen una actividad antagonista de taquiquinina,y son utiles como productos farmacéuticos, por ejemplo, para el tratamiento del dolor y migrana. Un procedimiento para la produccion de un derivado de laformula (I), o una sal de adicion de ácido del mismo, que comprende: a)hacer reaccionar un compuesto de la formula (II)con un compuesto de la formula (III),en donde Z es un grupo de salida; b) para la produccion de un compuesto de la formula (I), en donde X es -CO-, e Y es -O- o - S-, hacer reaccionar uncompuesto de la formula (II), con un compuesto de la formula (IV), en donde Z es un grupo de salida, e Y es -O- o -S-, o c) para la produccion de uncompuesto de la formula (I), en donde X es -CO-, e Y es -NH-, tratar uncompuesto de la formula (V) con un haluro de alquilo; y recuperar el derivadode la formula (I) así obtenido, en forma libre o de sal de adicion de ácido. Una composicion farmacéutica que comprende al derivado o una sal de adicion deácido farmacéuticamente aceptable del mismo, junto con un diluyente o vehículo farmacéuticamente aceptable para el mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9700597.9A GB9700597D0 (en) | 1997-01-14 | 1997-01-14 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR011521A1 true AR011521A1 (es) | 2000-08-30 |
Family
ID=10805904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980100097A AR011521A1 (es) | 1997-01-14 | 1998-01-09 | Un derivado de la prolil-3-(2-naftil) alanil-n-bencil-n-metilamida, un procedimiento para su preparacion y una composicion farmaceutica que lo comprende |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6107293A (es) |
| EP (1) | EP0964867B1 (es) |
| JP (2) | JP4306804B2 (es) |
| AR (1) | AR011521A1 (es) |
| AT (1) | ATE290546T1 (es) |
| AU (1) | AU5764298A (es) |
| CA (1) | CA2278057C (es) |
| CO (1) | CO4950614A1 (es) |
| DE (1) | DE69732715T2 (es) |
| ES (1) | ES2239368T3 (es) |
| GB (1) | GB9700597D0 (es) |
| PT (1) | PT964867E (es) |
| WO (1) | WO1998031704A2 (es) |
| ZA (1) | ZA98256B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6426331B1 (en) | 1998-07-08 | 2002-07-30 | Tularik Inc. | Inhibitors of STAT function |
| GB9815696D0 (en) * | 1998-07-20 | 1998-09-16 | Pfizer Ltd | Heterocyclics |
| AU759022B2 (en) | 1999-02-18 | 2003-04-03 | Kaken Pharmaceutical Co., Ltd. | Novel amide derivatives as growth hormone secretagogues |
| WO2001083517A1 (en) * | 2000-05-03 | 2001-11-08 | Tularik Inc. | Stat4 and stat6 binding dipeptide derivatives |
| US6884782B2 (en) | 2000-11-08 | 2005-04-26 | Amgen Inc. | STAT modulators |
| US20070219214A1 (en) * | 2006-02-01 | 2007-09-20 | Solvay Pharmaceuticals Gmbh | Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation |
| KR20090071581A (ko) | 2006-10-16 | 2009-07-01 | 라이온 가부시키가이샤 | Ｎｋ１ 수용체 앤태고니스트 조성물 |
| EP2729147B1 (en) | 2011-07-04 | 2017-09-06 | IRBM - Science Park S.p.A. | Nk-1 receptor antagonists for treating corneal neovascularisation |
| WO2019162519A1 (en) | 2018-02-26 | 2019-08-29 | Ospedale San Raffaele S.R.L. | Nk-1 antagonists for use in the treatment of ocular pain |
| EP4117673A1 (en) | 2020-03-11 | 2023-01-18 | Ospedale San Raffaele S.r.l. | Treatment of stem cell deficiency |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ210669A (en) * | 1983-12-27 | 1988-05-30 | Syntex Inc | Benzoxazin-4-one derivatives and pharmaceutical compositions |
| GB8929070D0 (en) * | 1989-12-22 | 1990-02-28 | Fujisawa Pharmaceutical Co | Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same |
| FR2719312B1 (fr) * | 1994-04-28 | 1996-06-14 | Adir | Nouveau pseudopeptides dérivés de neurokinines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
-
1997
- 1997-01-14 GB GBGB9700597.9A patent/GB9700597D0/en active Pending
- 1997-12-29 ES ES97953927T patent/ES2239368T3/es not_active Expired - Lifetime
- 1997-12-29 CA CA002278057A patent/CA2278057C/en not_active Expired - Fee Related
- 1997-12-29 EP EP97953927A patent/EP0964867B1/en not_active Expired - Lifetime
- 1997-12-29 US US09/341,626 patent/US6107293A/en not_active Expired - Lifetime
- 1997-12-29 WO PCT/EP1997/007307 patent/WO1998031704A2/en active IP Right Grant
- 1997-12-29 JP JP53360998A patent/JP4306804B2/ja not_active Expired - Fee Related
- 1997-12-29 DE DE69732715T patent/DE69732715T2/de not_active Expired - Lifetime
- 1997-12-29 PT PT97953927T patent/PT964867E/pt unknown
- 1997-12-29 AT AT97953927T patent/ATE290546T1/de not_active IP Right Cessation
- 1997-12-29 AU AU57642/98A patent/AU5764298A/en not_active Abandoned
-
1998
- 1998-01-09 AR ARP980100097A patent/AR011521A1/es active IP Right Grant
- 1998-01-13 CO CO98001002A patent/CO4950614A1/es unknown
- 1998-01-13 ZA ZA98256A patent/ZA98256B/xx unknown
-
2005
- 2005-11-29 JP JP2005344056A patent/JP3817256B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT964867E (pt) | 2005-07-29 |
| ES2239368T3 (es) | 2005-09-16 |
| ATE290546T1 (de) | 2005-03-15 |
| GB9700597D0 (en) | 1997-03-05 |
| JP2006089499A (ja) | 2006-04-06 |
| EP0964867A2 (en) | 1999-12-22 |
| ZA98256B (en) | 1998-07-14 |
| EP0964867B1 (en) | 2005-03-09 |
| JP3817256B2 (ja) | 2006-09-06 |
| DE69732715T2 (de) | 2006-04-13 |
| WO1998031704A3 (en) | 1998-09-11 |
| DE69732715D1 (de) | 2005-04-14 |
| WO1998031704A2 (en) | 1998-07-23 |
| AU5764298A (en) | 1998-08-07 |
| CO4950614A1 (es) | 2000-09-01 |
| JP4306804B2 (ja) | 2009-08-05 |
| JP2000516257A (ja) | 2000-12-05 |
| CA2278057C (en) | 2004-05-04 |
| US6107293A (en) | 2000-08-22 |
| CA2278057A1 (en) | 1998-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8705865A1 (es) | Procedimiento para preparar derivados de becimidazol sustituidos en posicion 5 | |
| PT99317A (pt) | Processo para a preparacao de novos compostos peptidicos e de composicoes farmaceuticas que os contem | |
| AR017021A1 (es) | Acido 2-hidroxiacetico | |
| EA200000682A1 (ru) | Новые ацилгуанидиновые производные в качестве ингибиторов резорбции костной ткани и антагонистов витронектиновых рецепторов | |
| AR029150A1 (es) | Un derivado de piperidina, su empleo, un procedimiento para prepararlo y una composicin farmaceutica que lo comprende. | |
| AR011521A1 (es) | Un derivado de la prolil-3-(2-naftil) alanil-n-bencil-n-metilamida, un procedimiento para su preparacion y una composicion farmaceutica que lo comprende | |
| BR0109109A (pt) | Composto, uso do mesmo, processo para prepará-lo, composição farmacêutica, e, método de tratar um estado doentio mediado por ccr5 em mamìferos | |
| ES2038172T3 (es) | Procedimiento para preparar carboxamidas heterociclicas. | |
| BR0215277A (pt) | Dicetopiperazinas substituìdas como antagonistas da oxitocina | |
| MY113863A (en) | Method for preparing n, n' - disubstituted cyclic ureas | |
| AR037521A1 (es) | Derivados de piperazina que tienen actividad antagonista del sst1, un proceso para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento para el tratamiento de la depresion, ansiedad y padecimientos bipolares y una combinacion | |
| PT90725A (pt) | Processo para a preparacao de novos compostos cefem | |
| ES2080726T3 (es) | Compuestos aromaticos o heteroaromaticos nitrosustituidos para su utilizacion en el tratamiento del cancer. | |
| EA200100969A1 (ru) | Новые соединения циклобутендиона, способ их получения и содержащие их фармацевтические композиции | |
| CO5590934A2 (es) | Procedimiento de preparacion de derivados de equinocandina | |
| UY24697A1 (es) | Metodos para producir inhibidores de vih-proteasa y productos intermedios para producir inhibidores de vih-proteasa | |
| ES2043070T3 (es) | Procedimiento para la preparacion de derivados de la benzotiazolamina-2. | |
| RU94046387A (ru) | Производные пиримидина, способ их получения, фармацевтическая композиция, ее применение и промежуточные продукты | |
| AR027578A1 (es) | Derivados de indano | |
| AR008371A1 (es) | Una sal de adicion con acido de una 10-aminoalifatil-dibenz[b,f],oxepina, su empleo; procedimiento para su elaboracion, una 10-aminoalifatil-dibenz[b,f]oxepina, una preparacion farmaceutica que contiene dicha sal o dicha oxepina y un procedimiento para el tratamiento de enfermedades neurodegenerativ | |
| EA200000374A2 (ru) | Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции | |
| DE3684186D1 (de) | Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen. | |
| BR9908452A (pt) | Composição fungicida que compreende uma benzoilfeniluréia | |
| GB967594A (en) | 2-(2,6-dimethyl-3-hydroxy-4-tert-butyl-benzyl)-2-imidazoline,and acid addition salts thereof,and process for their manufacture | |
| DE3577697D1 (de) | Basische oximether, pharmazeutische mittel gegen angina und die verwendung von basischen oximethern zur herstellung von arzneimitteln zur behandlung von angina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |